180 related articles for article (PubMed ID: 23661792)
1. Vaccine poliovirus shedding and immune response to oral polio vaccine in HIV-infected and -uninfected Zimbabwean infants.
Troy SB; Musingwini G; Halpern MS; Huang C; Stranix-Chibanda L; Kouiavskaia D; Shetty AK; Chumakov K; Nathoo K; Maldonado YA
J Infect Dis; 2013 Aug; 208(4):672-8. PubMed ID: 23661792
[TBL] [Abstract][Full Text] [Related]
2. Pediatric HIV Infection and Decreased Prevalence of OPV Point Mutations Linked to Vaccine-associated Paralytic Poliomyelitis.
Halpern MS; Altamirano J; Maldonado Y
Clin Infect Dis; 2018 Oct; 67(suppl_1):S78-S84. PubMed ID: 30376083
[TBL] [Abstract][Full Text] [Related]
3. Immunologic response to oral polio vaccine in human immunodeficiency virus-infected and uninfected Zimbabwean children.
Gnanashanmugam D; Troy SB; Musingwini G; Huang C; Halpern MS; Stranix-Chibanda L; Shetty AK; Kouiavskaia D; Nathoo K; Chumakov K; Maldonado YA
Pediatr Infect Dis J; 2012 Feb; 31(2):176-80. PubMed ID: 22146742
[TBL] [Abstract][Full Text] [Related]
4. Shedding of Oral Poliovirus Vaccine (OPV) by HIV-Infected and -Uninfected Mothers of OPV-Vaccinated Zimbabwean Infants.
Holubar M; Troy SB; Nathoo K; Stranix-Chibanda L; Musingwini G; Srinivas N; Huang C; Junn A; Halpern MS; Maldonado YA
J Pediatric Infect Dis Soc; 2017 Mar; 6(1):105-108. PubMed ID: 26759497
[TBL] [Abstract][Full Text] [Related]
5. Use of a novel real-time PCR assay to detect oral polio vaccine shedding and reversion in stool and sewage samples after a mexican national immunization day.
Troy SB; Ferreyra-Reyes L; Huang C; Mahmud N; Lee YJ; Canizales-Quintero S; Flaster H; Báez-Saldaña R; García-García L; Maldonado Y
J Clin Microbiol; 2011 May; 49(5):1777-83. PubMed ID: 21411577
[TBL] [Abstract][Full Text] [Related]
6. Sequential inactivated (IPV) and live oral (OPV) poliovirus vaccines for preventing poliomyelitis.
Ciapponi A; Bardach A; Rey Ares L; Glujovsky D; Cafferata ML; Cesaroni S; Bhatti A
Cochrane Database Syst Rev; 2019 Dec; 12(12):CD011260. PubMed ID: 31801180
[TBL] [Abstract][Full Text] [Related]
7. Inactivated poliovirus vaccine given alone or in a sequential schedule with bivalent oral poliovirus vaccine in Chilean infants: a randomised, controlled, open-label, phase 4, non-inferiority study.
O'Ryan M; Bandyopadhyay AS; Villena R; Espinoza M; Novoa J; Weldon WC; Oberste MS; Self S; Borate BR; Asturias EJ; Clemens R; Orenstein W; Jimeno J; Rüttimann R; Costa Clemens SA;
Lancet Infect Dis; 2015 Nov; 15(11):1273-82. PubMed ID: 26318714
[TBL] [Abstract][Full Text] [Related]
8. Community circulation patterns of oral polio vaccine serotypes 1, 2, and 3 after Mexican national immunization weeks.
Troy SB; Ferreyra-Reyes L; Huang C; Sarnquist C; Canizales-Quintero S; Nelson C; Báez-Saldaña R; Holubar M; Ferreira-Guerrero E; García-García L; Maldonado YA
J Infect Dis; 2014 Jun; 209(11):1693-9. PubMed ID: 24367038
[TBL] [Abstract][Full Text] [Related]
9. Vaccine-related poliovirus shedding in trivalent polio vaccine and human immunodeficiency virus status: analysis from under five children.
Hassan J; Wangai L; Borus P; Khayeka-Wandabwa C; Karani LW; Kithinji M; Kiptoo M
BMC Res Notes; 2017 Nov; 10(1):555. PubMed ID: 29100529
[TBL] [Abstract][Full Text] [Related]
10. Vaccine-derived polioviruses.
Burns CC; Diop OM; Sutter RW; Kew OM
J Infect Dis; 2014 Nov; 210 Suppl 1():S283-93. PubMed ID: 25316847
[TBL] [Abstract][Full Text] [Related]
11. The safety and immunogenicity of two novel live attenuated monovalent (serotype 2) oral poliovirus vaccines in healthy adults: a double-blind, single-centre phase 1 study.
Van Damme P; De Coster I; Bandyopadhyay AS; Revets H; Withanage K; De Smedt P; Suykens L; Oberste MS; Weldon WC; Costa-Clemens SA; Clemens R; Modlin J; Weiner AJ; Macadam AJ; Andino R; Kew OM; Konopka-Anstadt JL; Burns CC; Konz J; Wahid R; Gast C
Lancet; 2019 Jul; 394(10193):148-158. PubMed ID: 31174831
[TBL] [Abstract][Full Text] [Related]
12. Humoral and mucosal immunity in infants induced by three sequential inactivated poliovirus vaccine-live attenuated oral poliovirus vaccine immunization schedules. Baltimore Area Polio Vaccine Study Group.
Modlin JF; Halsey NA; Thoms ML; Meschievitz CK; Patriarca PA
J Infect Dis; 1997 Feb; 175 Suppl 1():S228-34. PubMed ID: 9203721
[TBL] [Abstract][Full Text] [Related]
13. Protocol Paper: Oral Poliovirus Vaccine Transmissibility in Communities After Cessation of Routine Oral Poliovirus Vaccine Immunization.
Sarnquist C; Holubar M; García-García L; Ferreyra-Reyes L; Delgado-Sánchez G; Cruz-Hervert LP; Montero-Campos R; Altamirano J; Purington N; Boyle S; Modlin J; Ferreira-Guerrero E; Canizales-Quintero S; Díaz Ortega JL; Desai M; Maldonado YA
Clin Infect Dis; 2018 Oct; 67(suppl_1):S115-S120. PubMed ID: 30376084
[TBL] [Abstract][Full Text] [Related]
14. Poliovirus vaccine shedding among persons with HIV in Abidjan, Cote d'Ivoire.
Hennessey KA; Lago H; Diomande F; Akoua-Koffi C; Caceres VM; Pallansch MA; Kew OM; Nolan M; Zuber PL
J Infect Dis; 2005 Dec; 192(12):2124-8. PubMed ID: 16288377
[TBL] [Abstract][Full Text] [Related]
15. Immune responses to oral poliovirus vaccine in HIV-exposed uninfected Zimbabwean infants.
Church JA; Rukobo S; Govha M; Carmolli MP; Diehl SA; Chasekwa B; Ntozini R; Mutasa K; Humphrey JH; Kirkpatrick BD; Prendergast AJ
Hum Vaccin Immunother; 2017 Nov; 13(11):2543-2547. PubMed ID: 28857649
[TBL] [Abstract][Full Text] [Related]
16. Case of Poliomyelitis Caused by Significantly Diverged Derivative of the Poliovirus Type 3 Vaccine Sabin Strain Circulating in the Orphanage.
Korotkova EA; Prostova MA; Gmyl AP; Kozlovskaya LI; Eremeeva TP; Baikova OY; Krasota AY; Morozova NS; Ivanova OE
Viruses; 2020 Sep; 12(9):. PubMed ID: 32883046
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of vaccine-derived polioviruses in stools of immunodeficient children in South Africa.
Pavlov DN; Van Zyl WB; Van Heerden J; Kruger M; Blignaut L; Grabow WO; Ehlers MM
J Appl Microbiol; 2006 Dec; 101(6):1367-79. PubMed ID: 17105568
[TBL] [Abstract][Full Text] [Related]
18. Quantity of Vaccine Poliovirus Shed Determines the Titer of the Serum Neutralizing Antibody Response in Indian Children Who Received Oral Vaccine.
Giri S; Kumar N; Dhanapal P; Venkatesan J; Kasirajan A; Iturriza-Gomara M; John J; Abraham AM; Grassly NC; Kang G
J Infect Dis; 2018 Apr; 217(9):1395-1398. PubMed ID: 29300947
[TBL] [Abstract][Full Text] [Related]
19. Screening for long-term poliovirus excretion among children with primary immunodeficiency disorders: preparation for the polio posteradication era in Bangladesh.
Sazzad HM; Rainey JJ; Kahn AL; Mach O; Liyanage JB; Alam AN; Kawser CA; Hossain A; Sutter R; Luby SP
J Infect Dis; 2014 Nov; 210 Suppl 1():S373-9. PubMed ID: 25316858
[TBL] [Abstract][Full Text] [Related]
20. Intestinal Immune Responses to Type 2 Oral Polio Vaccine (OPV) Challenge in Infants Previously Immunized With Bivalent OPV and Either High-Dose or Standard Inactivated Polio Vaccine.
Brickley EB; Strauch CB; Wieland-Alter WF; Connor RI; Lin S; Weiner JA; Ackerman ME; Arita M; Oberste MS; Weldon WC; Sáez-Llorens X; Bandyopadhyay AS; Wright PF
J Infect Dis; 2018 Jan; 217(3):371-380. PubMed ID: 29304199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
